Clinical Trials
2 trialsNCT05401214 2025-06-13
Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)
Janssen Research & Development, LLC
Approved for marketing
NCT03025867 2017-04-17
Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer
Tesaro, Inc.
Approved for marketing